XK and influenza: This study represents the first evidence that a centralized consensus NA vaccine can provide protection from influenza, contributes to the recent findings that consensus NAs could be an effective strategy to improve influenza vaccine efficacy [30,31], and supports further investigation into computational vaccine designs targeting the NA for its potential to induce cross-protection against strains from multiple species.